Your clients are asking about hedging. Now you have an answer.
A client calls with a concentrated stock position and asks about a collar. Or they're weighing an autocallable. You know enough to know it matters, but not enough to fully analyze the structure. That gap is expensive.
Verio Labs provides the derivatives expertise your practice needs without adding headcount. We work behind the scenes. Your client relationship stays yours.
What your current providers miss.
Most RIAs built their practice on financial planning, allocation, and client relationships. That's exactly right. But when a client shows up with an options question, a structured product, or a concentrated position that needs hedging, the honest answer is usually 'let me find someone.' You need analysis from someone independent — who doesn't have a product to sell and who gives you the work product, not the client relationship.
What we do for rias & advisors.
Scoped to your needs, delivered as auditable artifacts.
Structured note review
Your client is weighing a structured note. We decompose it on a governed pricing engine: what they're actually long and short, the embedded cost, the outcome probabilities, and whether a simpler alternative exists. Independent, with nothing to sell.
Trade structure analysis
Your client got pitched a trade or wants to explore hedging. We analyze the structure, cost, alternatives, and portfolio fit. You get a memo you can walk through with your client.
Scenario stress testing
What happens to your client's portfolio in a 2008 replay? A rates shock? A concentrated position gap-down? We run the scenarios and translate them into plain-language risk summaries.
Go deeper on your own.
Educational tools built from the same expertise that powers our advisory work.
New to options Greeks?
Our interactive course breaks down Delta, Gamma, Theta, Vega, and Rho through cinematic visualizations and live Black-Scholes math.
Exploring tail risk hedging?
Start with our comprehensive practitioner guide and AI-powered readiness assessment covering strategies, instruments, and governance.
Illustrative and for information only. Any figures are model-based estimates under stated assumptions, not appraisals or assurances of value; any backtests are hypothetical and not a predictor of results; case studies are anonymized and representative. Nothing here is investment advice or a recommendation to buy or sell any security. See our full disclosures.